Cargando…
Changing paradigm in advanced and metastatic non-small cell lung cancer
Lung cancer is the most common cancer worldwide. Approximately 18% of all deaths related to cancer are associated with lung cancer. Management of non-small cell lung cancer (NSCLC) has been changing rapidly in last few years. For patients with unresectable non-metastatic disease, maintenance durvalu...
Autores principales: | Uprety, Dipesh, Parikh, Kaushal, Sawkar, Anita, Dimou, Anastasios, Leventakos, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711369/ https://www.ncbi.nlm.nih.gov/pubmed/33282404 http://dx.doi.org/10.21037/jtd-20-1472 |
Ejemplares similares
-
Radiation and immunotherapy: emerging mechanisms of synergy
por: Breen, William G., et al.
Publicado: (2020) -
Current practice in thoracic neoplasm diagnosis, evaluation and treatment
por: Koo, Chi Wan
Publicado: (2020) -
Liquid biopsy is a valuable tool in the diagnosis and management of lung cancer
por: Cecchini, Matthew J., et al.
Publicado: (2020) -
Immunotherapy in patients with autoimmune disease
por: Rakshit, Sagar, et al.
Publicado: (2020) -
Image guided thermal ablation in lung cancer treatment
por: Lin, Miao, et al.
Publicado: (2020)